The DOI matches its Crossref record.
Using Artificial Intelligence (Watson for Oncology) for Treatment Recommendations Amongst Chinese Patients with Lung Cancer: Feasibility Study
Open accessPublished version of a preprint
Abstract
BACKGROUND: Artificial intelligence (AI) is developing quickly in the medical field and can benefit both medical staff and patients. The clinical decision support system Watson for Oncology (WFO) is an outstanding representative AI in the medical field, and it can provide to cancer patients prompt treatment recommendations comparable with ones made by expert oncologists. WFO is increasingly being used in China, but limited reports on whether WFO is suitable for Chinese patients, especially patients with lung cancer, exist. Here, we report a retrospective study based on the consistency between the lung cancer treatment recommendations made for the same patient by WFO and by the multidisciplinary team at our center. OBJECTIVE: The aim of this study was to explore the feasibility of using WFO for lung cancer cases in China and to ascertain ways to make WFO more suitable for Chinese patients with lung cancer. METHODS: We selected all lung cancer patients who were hospitalized and received antitumor treatment for the first time at the Second Xiangya Hospital Cancer Center from September to December 2017 (N=182). WFO made treatment recommendations for all supported cases (n=149). If the actual therapeutic regimen (administered by our multidisciplinary team) was recommended or for consideration according to WFO, we defined the recommendations as consistent; if the actual therapeutic regimen was not recommended by WFO or if WFO did not provide the same treatment option, we defined the recommendations as inconsistent. Blinded second round reviews were performed by our multidisciplinary team to reassess the incongruent cases. RESULTS: WFO did not support 18.1% (33/182) of recommendations among all cases. Of the 149 supported cases, 65.8% (98/149) received recommendations that were consistent with the recommendations of our team. Logistic regression analysis showed that pathological type and staging had significant effects on consistency (P=.004, odds ratio [OR] 0.09, 95% CI 0.02-0.45 and P<.001, OR 9.5, 95% CI 3.4-26.1, respectively). Age, gender, and presence of epidermal growth factor receptor gene mutations had no effect on consistency. In 82% (42/51) of the inconsistent cases, our team administered two China-specific treatments, which were different from the recommendations made by WFO but led to excellent outcomes. CONCLUSIONS: In China, most of the treatment recommendations of WFO are consistent with the recommendations of the expert group, although a relatively high proportion of cases are still not supported by WFO. Therefore, WFO cannot currently replace oncologists. WFO can improve the efficiency of clinical work by providing assistance to doctors, but it needs to learn the regional characteristics of patients to improve its assistive ability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 27
- 10.1016/S0140-6736(12)60774-0 · doi:10.1016/s0140-6736(12)60774-0
- 10.1016/S0140-6736(12)61367-1 · DOI
- 10.1016/S0140-6736(13)62401-0 · doi:10.1016/s0140-6736(13)62401-0
- 10.1016/S0140-6736(14)61436-7 · DOI
- 10.1016/j.ijcard.2016.08.104 · DOI
- 10.1016/j.puhe.2017.02.014 · doi:10.1016/j.puhe.2017.02.014
- 10.2190/HS.44.4.a · DOI · Paper page
- 10.1097/MD.0000000000005128 · DOI
- 10.1093/annonc/mdx781 · DOI · Paper page
- 10.1093/annonc/mdx678.001 · doi:10.1093/annonc/mdx678.001
- 10.1016/j.jtho.2017.09.723 · doi:10.1016/j.jtho.2017.09.723
- 10.1093/annonc/mdx676.024 · DOI
- 10.3322/caac.21442 · DOI · Paper page
- 10.1200/JCO.2012.45.3753 · DOI · Paper page
- 10.3978/j.issn.2218-6751.2014.09.01 · DOI
- 10.1200/JCO.2017.35.15_suppl.6589 · doi:10.1200/jco.2017.35.15_suppl.6589
- 10.1097/JTO.0000000000000343 · doi:10.1097/jto.0000000000000343
- 10.1111/1759-7714.12050 · DOI
- 10.4103/0019-509X.154099 · doi:10.4103/0019-509x.154099
- Han, B, 2011, Zhonghua Zhong Liu Za Zhi, 33, 854
- 10.1183/09031936.00156614 · DOI
- 10.1016/S1470-2045(13)70355-3 · DOI · Paper page
- 10.1016/j.hlpt.2017.05.002 · DOI
- 10.1016/j.healthplace.2016.09.005 · doi:10.1016/j.healthplace.2016.09.005
- 10.1111/dewb.12162 · doi:10.1111/dewb.12162
- 10.1016/j.ejrad.2018.06.020 · DOI · Paper page
- 10.1016/j.radonc.2018.05.030 · DOI · Paper page
Cited by
Ahmed, Z., Mohamed, K., Zeeshan, S., & Dong, X. (2020) · Database · doi:10.1093/database/baaa010 · Cited by 1,035
Fiske, A., Henningsen, P., & Buyx, A. (2019) · Journal of Medical Internet Research · doi:10.2196/13216 · Cited by 857
Artificial intelligence: a survey on evolution, models, applications and future trends
Lu, Y. (2019) · Journal of Management Analytics · doi:10.1080/23270012.2019.1570365 · Cited by 641
Xu, L., Sanders, L., Li, K., & Chow, J. C. L. (2021) · JMIR Cancer · doi:10.2196/27850 · Cited by 571
Role of Artificial Intelligence Applications in Real-Life Clinical Practice: Systematic Review
Yin, J., Ngiam, K. Y., & Teo, H. H. (2021) · Journal of Medical Internet Research · doi:10.2196/25759 · Cited by 419
Metadata
- Authors
- Liu, C., Liu, X., Wu, F., Xie, M., Feng, Y., & Hu, C.
- Venue
- Journal of Medical Internet Research
- Publisher
- JMIR Publications Inc.
- Published
- 2018-09-25
- Volume
- 20
- Issue
- 9
- Pages
- e11087
- ISSN
- 1438-8871 (ISSN-L)
- OpenAlex
- W2889346090
- Cited by
- 162
- References
- 0
- FWCI
- 2.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Using Artificial Intelligence (Watson for Oncology) for Treatment Recommendations Amongst Chinese Patients with Lung Cancer: Feasibility Study. https://app.cochat.ai/papers/10.2196/11087
- The paper
- Liu, C., Liu, X., Wu, F., Xie, M., Feng, Y., & Hu, C. (2018). Using Artificial Intelligence (Watson for Oncology) for Treatment Recommendations Amongst Chinese Patients with Lung Cancer: Feasibility Study. Journal of Medical Internet Research. https://doi.org/10.2196/11087
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.